| Basics |
| Company: |
Vaxart, Inc |
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$162.31M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.18 | 4.71%
|
| Avg Daily Range (30 D): |
$0.03 | 3.78%
|
| Avg Daily Range (90 D): |
$0.03 | 3.81%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.62M |
| Avg Daily Volume (30 D): |
1.16M |
| Avg Daily Volume (90 D): |
1.34M |
| Trade Size |
| Avg Trade Size (Sh.): |
284 |
| Avg Trade Size (Sh.) (30 D): |
499 |
| Avg Trade Size (Sh.) (90 D): |
581 |
| Institutional Trades |
| Total Inst.Trades: |
1,213 |
| Avg Inst. Trade: |
$1.7M |
| Avg Inst. Trade (30 D): |
$.6M |
| Avg Inst. Trade (90 D): |
$.6M |
| Avg Inst. Trade Volume: |
.28M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.86M |
| Avg Closing Trade (30 D): |
$.6M |
| Avg Closing Trade (90 D): |
$.6M |
| Avg Closing Volume: |
382.4K |
|
|
|
|
| News |
Jun 17, 2024 @ 8:32 PM
Vaxart Stock Is Moving Higher After The Bell: What...
Source: Adam Eckert
|
Jun 17, 2024 @ 8:05 PM
Vaxart Provides Business Update
Source: Vaxart, Inc.
|
Jun 13, 2024 @ 11:07 PM
Vaxart Announces $40 Million Underwritten Offering...
Source: Vaxart, Inc.
|
Jun 13, 2024 @ 8:15 PM
Vaxart Receives BARDA-Funded Project NextGen Award...
Source: Vaxart, Inc.
|
May 23, 2024 @ 8:01 PM
Vaxart, Inc. Reports Inducement Grants Under Nasda...
Source: Vaxart, Inc.
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-.4
|
$-.06
|
$-.09
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ 16.76M
|
$ 4.93M
|
$ 6.4M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -72.34M
|
$ -14.08M
|
$ -16.47M
|
|
Operating Income / Loss
|
$ -71.7M
|
$ -14.48M
|
$ -16.26M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -11.2M
|
$ -21.25M
|
$ 16.55M
|
|
PE Ratio
|
|
|
|
| Splits |
| Feb 14, 2018:
11:1
|
| Nov 09, 2012:
6:1
|
|
